Sarepta Therapeutics (SRPT) PT Lowered to $45 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Yanan Zhu ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
